Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine
Endocrine Connections Sep 04, 2017
Gasior–Perczak D, et al. – The aim of this study was to evaluate the delayed risk stratification (DRS) system in patients with pT1aN0/Nx stage. It was demonstrated that the delayed risk stratification system was not feasible for predicting the risk of unfavorable clinical outcomes and cannot be used to personalize the monitoring method of the disease in patients at pT1aN0/Nx stage who are not treated with radioactive iodine.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
